Company Description
DHAIW represents warrants of DIH Holding US, Inc., a company associated with the Surgical & Medical Instruments & Apparatus sector. According to Nasdaq listing information disclosed in regulatory filings, these warrants have been listed on The Nasdaq Stock Market LLC. The available data connects DHAIW directly to DIH Holding US, Inc., which is the issuer referenced in the company’s SEC reports.
Public disclosures indicate that DIH Holding US, Inc. has faced challenges in maintaining its Nasdaq listing standards. In an 8-K filing, the company reported that its securities, including the warrants trading under the symbol DHAIW, were subject to potential delisting from Nasdaq. The issues cited included non-compliance with minimum bid price requirements, minimum market value of listed securities thresholds, and timely filing of required periodic reports with the SEC.
The same 8-K filing explains that DIH Holding US, Inc. requested a hearing before a Nasdaq Hearing Panel. This request temporarily stayed the suspension of the company’s common stock for a limited period and formed part of the company’s efforts to present a plan to regain compliance with Nasdaq’s listing criteria. The filing notes that there was no assurance that the panel would grant continued listing or that the company would be able to demonstrate compliance within any extension that might be provided.
Another 8-K filing from DIH Holding US, Inc. reports a change in senior leadership. The company disclosed that its Chief Executive Officer resigned from that position and from similar roles at its subsidiaries, while remaining a member of the Board of Directors. The Board had not yet appointed a replacement at the time of that filing. This leadership change is a material corporate event that may be relevant to investors evaluating the company and, by extension, the warrants represented by the symbol DHAIW.
Because the primary available information about DHAIW comes from SEC filings related to listing compliance and corporate governance, investors and researchers often focus on regulatory status, listing conditions, and governance developments when examining this symbol. These disclosures provide insight into the trading status and corporate circumstances surrounding DIH Holding US, Inc. and its warrants.
Trading and listing context
In the 8-K describing notice of delisting or failure to satisfy continued listing standards, DIH Holding US, Inc. details how its securities, including the warrants identified as DHAIW, were affected by Nasdaq rules. The filing references specific Nasdaq Listing Rules related to bid price, market value of listed securities, and timely filing of periodic reports. This context underscores that the trading status of DHAIW is closely tied to the company’s overall compliance with exchange requirements.
Corporate governance developments
The reported resignation of the Chief Executive Officer, while he remained on the Board, highlights governance changes that can influence perceptions of the company’s direction. The 8-K notes that the Board had not yet appointed a successor at the time of the filing. Such changes are part of the broader picture investors may consider when evaluating warrants like DHAIW that are linked to the issuer’s equity and corporate condition.
Use of regulatory information
For a symbol such as DHAIW, where public descriptions of the underlying business are limited, SEC filings become a primary source of information. The company’s 8-K filings describe material events, listing status, and governance changes that can affect how market participants view the warrants. These documents help clarify the regulatory environment in which the securities trade and outline the steps the company has taken in response to exchange notices.
Stock Performance
DIH Holdings US (DHAIW) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%.
Latest News
SEC Filings
DIH Holdings US has filed 3 recent SEC filings, including 2 Form 8-K, 1 Form 25-NSE. The most recent filing was submitted on January 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DHAIW SEC filings →
Financial Highlights
DIH Holdings US generated $62.9M in revenue over the trailing twelve months, retaining a 51.2% gross margin, operating income reached -$7.0M (-11.2% operating margin), and net income was -$8.7M, reflecting a -13.8% net profit margin. Diluted earnings per share stood at $-6.07. The company generated -$4.1M in operating cash flow. With a current ratio of 0.49, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in DIH Holdings US (DHAIW) currently stands at 8.7 thousand shares, down 0.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 85.4%. This relatively low short interest suggests limited bearish sentiment. With 395.9 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for DIH Holdings US (DHAIW) currently stands at 395.9 days, up 38337.9% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 39491% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 395.9 days.
DHAIW Company Profile & Sector Positioning
DIH Holdings US (DHAIW) operates in the Surgical & Medical Instruments & Apparatus sector and is listed on the OTC Link.